To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
WP backs fourth pharma spin-out
Warburg Pincus has provided E60m in funding for the bone disease research division of French pharmaceutical giant Aventis.
